ADDvise signs global agreement with Laborie worth at least 38 MSEK.

ADDvise subsidiary Sonesta Medical AB, which develops and manufactures medical devices for the urology/gynecology and incontinence market, has signed a global distribution agreement with Toronto, Canada based Laborie Medical Technologies, Inc.  The initial period for the agreement is three years. Sales during this period is estimated to be worth at least 38 million SEK.

This global distribution agreement is obviously a milestone for the Sonesta business. Laborie has been for several years one of Sonesta's distributors, primarily in the US, and the companies have now agreed to further strengthen their relationships on a global basis, says Rikard Akhtarzand CEO for the ADDvise Group in a comment to the agreement. 

Laborie is the leading global developer, manufacturer and marketer of innovative medical technology and consumables used for the diagnosis and treatment of Urinary and Fecal Incontinence, as well as other pelvic floor disorders in the Urology, Gynecology, and Colorectal fields. The Sonesta products are an essential part of the complete solutions offered by Laborie. Laborie is a global company and markets its products in over 80 countries.

Rikard Aktharzand, VD +46 765-25 90 71


About ADDvise Lab Solutions AB

ADDvise Lab Solutions AB (publ) is an expansive group which through its subsidiaries IM-Medico Svenska AB, KEBO Inredningar Sverige AB, ADDvise Tillquist AB, Sonesta Medical AB, Sonesta Medical Inc och Surgical Tables Inc. offers comprehensive solutions in the form of products and services to healthcare and research facilities. ADDvise Group's customers are located in both the private and public sectors. The Company's share is listed on First North and Mangold Fondkommission AB, +46 8-503015 50, is the company's Certified Adviser and liquidity provider.

About Us

ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The group consists of approximately 10 subsidiaries organized into two business areas, Lab and Healthcare. Sales are global. The Group has a clear acquisition strategy with the aim of raising shareholder value and expand the business – both geographically and product wise. The Group has sales of about 250 MSEK. ADDvise shares are listed on Nasdaq First North Premier. Additional information is available at